Saudi Pharmaceutical Industries and Medical Appliances First Quarter 2024 Earnings: EPS: ر.س0.30 (vs ر.س0.46 in 1Q 2023)

Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) First Quarter 2024 Results

Key Financial Results

• Revenue: ر.س475.4m (down 11% from 1Q 2023).
• Net income: ر.س39.9m (down 27% from 1Q 2023).
• Profit margin: 8.4% (down from 10% in 1Q 2023).
• EPS: ر.س0.30 (down from ر.س0.46 in 1Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Saudi Pharmaceutical Industries and Medical Appliances Earnings Insights

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 9.8% growth forecast for the Pharmaceuticals industry in Asia.

Performance of the market in Saudi Arabia.

The company's shares are down 4.9% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Saudi Pharmaceutical Industries and Medical Appliances, and understanding this should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.